G. Rogler

Discipline

Psychologie (6) Anthropologie biologique (2)

Discipline

Etudes classiques (1)

Type de document

Articles (41) Recensions (3) Colloques et conférences (3)

Type de document

Livres et chapitres d'ouvrages (1)

Co-auteur

Date

Date

Source

Source

Mot-clé

Patients (37) Patients (37) Inflammatory bowel diseases (34) cohorte (31) Swiss (29) maladie (28) maladie (27) Ulcerative colitis (25) Crohn's disease (23) Human beings (22) Treatment (19) thérapie (14) Therapeutics (14) Manufacturers' agents (14) Commission merchants (14) Colitis (14) risque (13) Risk (13) Impact (13) adulte (12) adulte (12) Risk factors (11) Diagnosis (10) Diagnosis (10) Older people (10) temps (durée) (9) association (9) Surgery (9) Inhibitors (9) Time (9)

Mot-clé

Italie (1) Rome (1) Schools, French (1) Pictures (1) Bacchanalia (1) Library (1) Bacanales (1) Imágenes (1) Bibliothèque (1) Bacchanales (1) Bibliothèque (1) Écoles françaises (1) Illustrations, images, etc. (1) Rome (1) Rome (1) Italie (1) Athènes (1)

Documents écrit par G. Rogler (41) | parle de G. Rogler (1)

Lifestyle factors associated with inflammatory bowel disease: data from the Swiss IBD cohort study.
S.A. Lautenschlager et al. (12 mars 2023)
Alcohol and cannabis consumption in patients with inflammatory bowel disease: prevalence, pattern of consumption and impact on the disease.
I. Kapoglou et al. (1 janv. 2023)
Concomitant 5-aminosalicylic acid treatment does not affect 6-thioguanine nucleotide levels in patients with inflammatory bowel disease on thiopurines.
R. Looser et al. (2023)
The personality traits activity, self-reproach, and negative affect jointly predict clinical recurrence, depressive symptoms, and low quality of life in inflammatory bowel disease patients.
SBU Jordi et al.
Effect of closed and permanent stoma on disease course, psychological well-being and working capacity in Swiss IBD cohort study patients.
R. Bianchi et al. (2022)
Effectiveness of golimumab in patients with ulcerative colitis: results of a real-life study in Switzerland.
K. Perrig et al. (2022)
The impact of colectomy on the course of extraintestinal manifestations in Swiss inflammatory bowel disease cohort study patients.
R. Roth et al.
Genotype-phenotype associations of polymorphisms within the gene locus of NOD-like receptor pyrin domain containing 3 in Swiss inflammatory bowel disease patients.
P. Yoganathan et al. (3 août 2021)
Factors influencing the outcome of vedolizumab treatment: Real-life data with objective outcome measurements.
O. Mader et al.
Abdominal pain in patients with inflammatory bowel disease: association with single-nucleotide polymorphisms prevalent in irritable bowel syndrome and clinical management.
M. Ledergerber et al. (5 févr. 2021)
Effects of anti-TNF therapy and immunomodulators on anxiety and depressive symptoms in patients with inflammatory bowel disease: a 5-year analysis.
A.R. Siebenhüner et al. (2021)
The Influence of Breastfeeding, Cesarean Section, Pet Animals, and Urbanization on the Development of Inflammatory Bowel Disease: Data from the Swiss IBD Cohort Study.
S.A. Lautenschlager et al.
Effect of distance to specialist care for the diagnosis and disease outcome of inflammatory bowel disease in the Swiss inflammatory bowel disease cohort study.
L. Grob et al. (2020)
Genetic risk factors predict disease progression in Crohn's disease patients of the Swiss inflammatory bowel disease cohort.
F. Ditrich et al. (2020)
Position statement on the use of biosimilars in inflammatory bowel disease.
E. Burri et al. (2 déc. 2019)
The EBI2-oxysterol axis promotes the development of intestinal lymphoid structures and colitis.
A. Wyss et al.
The impact of the rs8005161 polymorphism on G protein-coupled receptor GPR65 (TDAG8) pH-associated activation in intestinal inflammation.
I.V. Tcymbarevich et al. (7 janv. 2019)
Occurrence of skin manifestations in patients of the Swiss Inflammatory Bowel Disease Cohort Study.
N. Roth et al. (2019)
Uveitis manifestations in patients of the Swiss Inflammatory Bowel Disease Cohort Study.
L. Biedermann et al. (2019)
The appearance of joint manifestations in the Swiss inflammatory bowel disease cohort.
A. Hiller et al. (2019)
Association of IBD specific treatment and prevalence of pain in the Swiss IBD cohort study.
L. Bon et al. (2019)
Frequency and type of drug-related side effects necessitating treatment discontinuation in the Swiss Inflammatory Bowel Disease Cohort.
S. Godat et al.
Expression Patterns of TNFα, MAdCAM1, and STAT3 in Intestinal and Skin Manifestations of Inflammatory Bowel Disease.
S.R. Vavricka et al. (28 févr. 2018)
The presence of genetic risk variants within PTPN2 and PTPN22 is associated with intestinal microbiota alterations in Swiss IBD cohort patients.
B. Yilmaz et al. (2018)
Low serum zinc levels predict presence of depression symptoms, but not overall disease outcome, regardless of ATG16L1 genotype in Crohn's disease patients.
T. Greuter et al. (2018)

next
Bacchanalia. La répression de 186 av. J.-C. à Rome et en Italie : Vestiges, images, tradition
Jean Pailler (1988)